CTI BIOPHARMA CORP.

CTI BIOPHARMA CORP. specializes in the manufacturing of pharmaceutical preparations, focusing on the development, production, and quality-controlled formulation of finished drug products in compliance with cGMP standards. Their technical expertise centers on active pharmaceutical ingredient processing, dosage form development, and regulatory-compliant manufacturing processes for oral, injectable, or other solid and liquid dosage forms. The company demonstrates proficiency in batch documentation, stability testing, and process validation essential for FDA-regulated pharmaceutical output. Their operational model emphasizes precision manufacturing and supply chain integrity tailored to government healthcare requirements. The contractor has delivered pharmaceutical manufacturing services to the Department of Veterans Affairs, supporting the agency’s mission to provide consistent, high-quality medication access to veteran populations. This engagement suggests a relationship rooted in reliable, mission-critical supply of therapeutics, likely involving contract production of branded or generic medications used in VA healthcare facilities. The nature of the recent award—an administration change—indicates ongoing operational continuity in existing supply agreements, reflecting established trust in their manufacturing reliability. The primary industry focus is pharmaceutical preparation manufacturing under NAICS 325412, positioning the company within the niche of contract pharmaceutical production rather than drug discovery or distribution. This vertical requires deep familiarity with FDA 21 CFR Part 211, analytical method validation, and controlled environments. CTI BIOPHARMA CORP. operates as a small business entity structured as a 2L (likely a limited liability company) based in Seattle, Washington. While no federal certifications are listed, their ability to secure government pharmaceutical contracts implies adherence to stringent quality systems and regulatory compliance frameworks required for federal supply chain participation. Their geographic presence supports access to West Coast logistics networks and biopharmaceutical talent pools.